The $7 million federal investment supports the training and education facility at Kansas State University
Kansas State University has announced a $7 million federal investment in support of its’ Biomanufacturing Training and Education Initiative. The funding for the program will be directed toward construction of the university’s new Biomanufacturing Core and Training Facility, 1 of 4 state-of-the-art facilities considered integral to the initiative.1
The facility, to be built on the university’s campus in Manhattan, Kansas, has an emphasis on production and training. It will be used to support partners in the advancement of diagnostics, prophylactics, and therapeutic countermeasures used to combat infectious animal diseases.1,2 It will also place a focus on zoonotic and foreign animal diseases, while providing Kansas State research students with crucial, hands-on experience.
“As Kansas continues to grow its’ animal health corridor, Kansas State University is uniquely equipped to train the workforce need for this industry,” Jerry Moran, US Senator for Kansas, said in a news release.1 “I worked to secure federal resources to bolster [Kansas State’s] efforts to build Manhattan into a premier location for biotechnology and biodefense companies looking to expand.”
By focusing on advancements in biomanufacturing, the university hopes to strengthen Kansas’ economy, attracting jobs and industry partners to the state. Currently, according to the Kansas Department of Commerce, the state’s animal health industry contributes more than $2.2 billion to Kansas’ total gross domestic product (GDP), with more than 14,000 Kansans currently employed in animal health related industries. Additionally, Kansas is home to the Animal Health Corridor, which has the largest concentration of animal health companies in the world, accounting for 56% of the total worldwide animal health, diagnostics, and pet food sales.3
“We are incredibly grateful to Senator Moran for supporting us to receive this federal funding. With it, [Kansas State] is positioned to have a lasting impact on both the health of Kansans, and the health of the economy,” Richard Linton, Kansas State University President, said.1 “Our work in biomanufacturing not only addresses current health challenges but will also pave the way for future innovation as the next-generation land-grant university.”
The university’s Biomanufacturing Training and Education Initiative features 3 additional facilities as part of its long-term plans:
References
Size of Phoenix pharmacy compounding facility has nearly doubled
December 11th 2024Covetrus announced the expansion of its' site in Arizona, increasing the company’s pharmacy capabilities for producing compounded products for use in veterinary clinics and pet owners' homes throughout the US
Read More